To be honest, based on the failed FDA approval originally, you...

To be honest, based on the failed FDA approval originally, you would think that once it came, it would head north back near the IPO price.

It didnt happen. People who bought in at .01c sold off for a monster 1700% gain and are happy. They don't need further interest in the stock, their game was played and made.

Those who see longer term value in the stock would have bought in on the drop from .17c or around the 9's to 10'x based on the 6 month average. The CR burned everyone and honestly it was stupid to CR at that price - i cant fathom the reasoning behind that.

Now it is a slow, slow burn back to the top given what is going on, no matter the news coming out.

I think people see the European sales as a precursor to the US sales which will be so far different it isn't funny. Henry Schein will be a precursor to other major signings. If the likes of Cardinal or McKesson come on board, you would think that would solidify the US market hold. It would be a matter of what hasn't happened in the US vs what has.

We will see an announcement out about the $5Milion received, net even quarterly, CLIA waiver and then it would take off. How long that takes? Beyond me.